0000882104-19-000041.txt : 20190416 0000882104-19-000041.hdr.sgml : 20190416 20190416171801 ACCESSION NUMBER: 0000882104-19-000041 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190328 FILED AS OF DATE: 20190416 DATE AS OF CHANGE: 20190416 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jene Jill M. CENTRAL INDEX KEY: 0001742105 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 19751672 MAIL ADDRESS: STREET 1: 932 SOUTHWOOD BLVD. CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 BUSINESS PHONE: 775-832-8500 MAIL ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 4/A 1 wf-form4a_155544946729502.xml FORM 4/A X0306 4/A 2019-03-28 2019-04-01 0 0000882104 PDL BIOPHARMA, INC. PDLI 0001742105 Jene Jill M. 932 SOUTHWOOD BLVD. INCLINE VILLAGE NV 89451 0 1 0 0 VP, Business Development Stock Option (right to buy) 3.72 2019-03-28 4 A 0 384615 0 A 2029-03-28 Common stock 384615.0 384615 D The number of shares included in the original April 1, 2019 Form 4 filing was incorrect and the Company is filing this amendment to correct the number of shares in the award grant. The stock options will vest as follows: (a) 25% of the shares subject to the option shall vest on the one year anniversary of January 1, 2019 and (b) 75% of the shares subject to the option shall vest on a monthly basis pro rata over the thirty-six (36) months following the one year anniversary of January 1, 2019, provided that the recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control and certain qualifying terminations of employment provided in the severance agreement between the issuer and the recipient. /s/ Nathan N. Kryszak, Attorney-In-Fact for Jill Jene 2019-04-16